793672-17-0

Basic information

• Product Name: thanone, 2-chloro-1-(2,3-dihydro-6-Methoxy-1H-indol-1-yl)-
• Synonyms: thanone, 2-chloro-1-(2,3-dihydro-6-Methoxy-1H-indol-1-yl)-;2-Chloro-1-(6-Methoxyindolin-1-yl)ethanone
• CAS NO: 793672-17-0
• Molecular Formula: C11H12ClNO2
• Molecular Weight: 225.67148
• Mol File: 793672-17-0.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: thanone, 2-chloro-1-(2,3-dihydro-6-Methoxy-1H-indol-1-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: thanone, 2-chloro-1-(2,3-dihydro-6-Methoxy-1H-indol-1-yl)-(793672-17-0)
• EPA Substance Registry System: thanone, 2-chloro-1-(2,3-dihydro-6-Methoxy-1H-indol-1-yl)-(793672-17-0)

Safety Data

• Hazardous Substances Data: 793672-17-0(Hazardous Substances Data)

Upstream product

• 3189-13-7 6-methoxylindole 
• 7556-47-0 6-methoxy-2,3-dihydro-1H-indole 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 793672-18-1 2-dimethylamino-1-(6-methoxy-2,3-dihydroindol-1-yl)ethanone 

Relevant articles and documents

Novel 5-HT7 receptor inverse agonists. Synthesis and molecular modeling of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides.

A series of arylpiperazine- and 1,2,3,4-tetrahydroisoquinoline-based arylsulfonamides was synthesized and evaluated for their interactions with the constitutively active 5-HT7 receptor. Effects on basal adenylate cyclase activity were measured using HEK-293 cells expressing the rat 5-HT7. All ligands produced a decrease of adenylate cyclase activity, indicative of their inverse agonism. Additionally, computational studies with a set of 22 inverse agonists, including these novel inverse agonists and inverse agonists known from literature, resulted in a pharmacophore model and a CoMFA model (R2 = 0.97, SE = 0.18). Docking of inverse agonists at the binding site of a model of the helical parts of the 5-HT7 receptor, based on the alpha carbon template for 7-TM GPCRs, revealed interesting molecular interactions and a possible explanation for observed structure-activity relationships.